CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeys.
- Systemic administration of CCK-8S (1 or 10 micrograms/kg IP) markedly inhibited L-dopa-induced dyskinesias in parkinsonian monkeys, but did not interfere with locomotor stimulation by L-dopa. CCK analogues may be useful antidyskinetic agents for improved control of Parkinson's disease.
- Publication status:
- Publisher copy:
- Copyright date: